Companies
Fractyl Health faces Nasdaq delisting notice, intends to seek hearing
The company missed its September 9 deadline to regain minimum bid-price compliance. It intends to request a hearing that would stay suspension or delisting, while a reverse-split proposal remains subject to stockholder approval.
